Salomon & Ludwin’s Astera Labs ALAB Stock Holding History

Salomon & Ludwin’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.9K	Hold	95	–	–	﹤0.01%	650
2026 Q1	$11.1K	Hold	95	–	–	﹤0.01%	1479
2025 Q4	$15.9K	Hold	95	–	–	﹤0.01%	1086
2025 Q3	$19.1K	Buy	+95	New	+$15.6K	﹤0.01%	843

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Salomon & Ludwin's ALAB Position: Q2 2026 in Review

Salomon & Ludwin held its Astera Labs (ALAB) position steady in Q2 2026 at 95 shares worth $40.9K. The position accounts for ﹤0.01% of the portfolio, ranked #650.

Salomon & Ludwin first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 991 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Salomon & Ludwin held 95 shares of Astera Labs worth $40.9K as of Q2 2026.
Salomon & Ludwin left its Astera Labs share count unchanged in Q2 2026.
Astera Labs made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #650 holding.
Salomon & Ludwin first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
991 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.